S&P 500 Futures
(0.27%) 5 145.50 points
Dow Jones Futures
(0.28%) 38 548 points
Nasdaq Futures
(0.38%) 17 914 points
Oil
(-0.82%) $83.16
Gas
(1.30%) $1.948
Gold
(-0.11%) $2 344.70
Silver
(1.20%) $27.58
Platinum
(0.62%) $927.80
USD/EUR
(-0.26%) $0.932
USD/NOK
(-0.20%) $11.00
USD/GBP
(-0.37%) $0.797
USD/RUB
(0.87%) $92.68

Realaus laiko atnaujinimai Pfizer Limited [PFIZER.NS]

Birža: NSE Sektorius: Healthcare Pramonė: Drug Manufacturers—General
Atnaujinta29 bal. 2024 @ 08:36

-0.07% INR 4 190.90

Live Chart Being Loaded With Signals

Commentary (29 bal. 2024 @ 08:36):

Pfizer Limited manufactures, markets, trades in, and exports pharmaceutical products in India and internationally. The company offers its products in various therapeutic areas, including neuro/central nervous system, hormones, cardiovascular, hemophilia, anti-infectives, gynecology, pain/analgesics, orthopedic, oncology, urology, anti-parasitic, gastro intestinal, vaccines, respiratory, and vitamins/minerals/nutrients...

Stats
Šios dienos apimtis 6 983.00
Vidutinė apimtis 33 900.00
Rinkos kapitalizacija 191.72B
EPS INR0 ( 2024-02-09 )
Kita pelno data ( INR0 ) 2024-05-12
Last Dividend INR5.00 ( 2023-08-11 )
Next Dividend INR0 ( N/A )
P/E 38.14
ATR14 INR5.30 (0.13%)

Tūris Koreliacija

Ilgas: -0.11 (neutral)
Trumpas: -0.02 (neutral)
Signal:(41.93) Neutral

Pfizer Limited Koreliacija

10 Labiausiai teigiamai susiję koreliacijos
10 Labiausiai neigiamai susiję koreliacijos

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Pfizer Limited Koreliacija - Valiuta/Žaliavos

The country flag -0.58
( weak negative )
The country flag -0.45
( neutral )
The country flag 0.31
( neutral )
The country flag -0.62
( weak negative )
The country flag 0.12
( neutral )
The country flag 0.01
( neutral )

Pfizer Limited Finansinės ataskaitos

Annual 2022
Pajamos: INR24.25B
Bruto pelnas: INR15.51B (63.97 %)
EPS: INR136.38
FY 2022
Pajamos: INR24.25B
Bruto pelnas: INR15.51B (63.97 %)
EPS: INR136.38
FY 2022
Pajamos: INR26.11B
Bruto pelnas: INR16.63B (63.68 %)
EPS: INR133.89
FY 2021
Pajamos: INR22.38B
Bruto pelnas: INR14.41B (64.36 %)
EPS: INR108.77

Financial Reports:

No articles found.

Pfizer Limited Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
INR65.00
(N/A)
INR0
(N/A)
INR0
(N/A)
INR0
(N/A)
INR5.00
(N/A)
INR0
(N/A)
INR0
(N/A)
INR0
(N/A)
INR0
(N/A)
INR0
(N/A)

Pfizer Limited Dividend Information - Dividend Junior

Dividend Sustainability Score: 3.96 - low (31.71%) | Divividend Growth Potential Score: 4.90 - Stable (1.94%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information
First Dividend INR7.50 2003-03-12
Last Dividend INR5.00 2023-08-11
Next Dividend INR0 N/A
Payout Date 0000-00-00
Next Payout Date N/A
# dividends 25 --
Total Paid Out INR1 006.50 --
Avg. Dividend % Per Year 0.82% --
Score 2.41 --
Div. Sustainability Score 3.96
Div.Growth Potential Score 4.90
Div. Directional Score 4.43 --
Next Divdend (Est)
(2024-05-20)
INR0 Estimate 3.21 %
Dividend Stability
0.26 Very Poor
Dividend Score
2.41
Pay Frequency
Annually
Yearly Payout
Year Amount Yield
2003 INR0 0.00%
2004 INR0 0.00%
2005 INR0 0.00%
2006 INR0 0.00%
2007 INR0 0.00%
2008 INR0 0.00%
2009 INR0 0.00%
2010 INR0 0.00%
2011 INR0 0.00%
2012 INR0 0.00%
2013 INR0 0.00%
2014 INR0 0.00%
2015 INR0 0.00%
2016 INR0 0.00%
2017 INR0 0.00%
2018 INR20.00 0.80%
2019 INR22.50 0.78%
2020 INR330.00 7.80%
2021 INR5.00 0.09%
2022 INR65.00 1.27%
2023 INR5.00 0.11%
2024 INR0 0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for NSE

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
SHIVALIK.NS Dividend Junior 2023-09-22 Annually 3 0.03%
MANORAMA.NS Dividend Junior 2023-09-11 Insufficient data to determine frequency 2 0.07%
GRAVITA.NS Dividend Junior 2023-09-04 Annually 14 0.72%
BAJAJHLDNG.NS Dividend Junior 2023-09-29 Annually 22 1.20%
UBL.NS Dividend Junior 2023-08-03 Annually 17 0.27%
POLYCAB.NS Dividend Knight 2023-06-21 Annually 6 0.50%
JSL.NS Dividend Junior 2023-09-15 Sporadic 22 0.26%
DLF.NS Dividend Junior 2023-07-28 Annually 18 0.60%
AARON.NS Dividend Junior 2023-08-28 Sporadic 5 0.36%
SOUTHBANK.NS Dividend Junior 2023-08-17 Sporadic 25 0.42%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM0.2261.5005.478.21[0 - 0.5]
returnOnAssetsTTM01.20000[0 - 0.3]
returnOnEquityTTM0.1551.5009.3910.00[0.1 - 1]
payoutRatioTTM0-1.00000[0 - 1]
currentRatioTTM00.800-5.00-4.00[1 - 3]
quickRatioTTM00.800-4.71-3.76[0.8 - 2.5]
cashRatioTTM01.500-1.111-1.667[0.2 - 2]
debtRatioTTM0-1.50000[0 - 0.6]
interestCoverageTTM62.741.00010.0010.00[3 - 30]
operatingCashFlowPerShareTTM35.542.0010.0010.00[0 - 30]
freeCashFlowPerShareTTM35.542.0010.0010.00[0 - 20]
debtEquityRatioTTM0-1.50000[0 - 2.5]
grossProfitMarginTTM0.6311.0002.822.82[0.2 - 0.8]
operatingProfitMarginTTM0.3111.0005.795.79[0.1 - 0.6]
cashFlowToDebtRatioTTM01.000-1.111-1.111[0.2 - 2]
assetTurnoverTTM00.800-3.33-2.67[0.5 - 2]
Total Score3.96

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM38.211.0006.240[1 - 100]
returnOnEquityTTM0.1552.509.6110.00[0.1 - 1.5]
freeCashFlowPerShareTTM35.542.0010.0010.00[0 - 30]
dividendYielPercentageTTM0.1191.5007.020[0 - 0.4]
operatingCashFlowPerShareTTM35.542.0010.0010.00[0 - 30]
payoutRatioTTM01.50000[0 - 1]
pegRatioTTM1.6541.5002.300[0.5 - 2]
operatingCashFlowSalesRatioTTM0.07331.000-0.6680[0.1 - 0.5]
Total Score4.90

Pfizer Limited

Pfizer Limited manufactures, markets, trades in, and exports pharmaceutical products in India and internationally. The company offers its products in various therapeutic areas, including neuro/central nervous system, hormones, cardiovascular, hemophilia, anti-infectives, gynecology, pain/analgesics, orthopedic, oncology, urology, anti-parasitic, gastro intestinal, vaccines, respiratory, and vitamins/minerals/nutrients. It sells its products through a network of independent distributors primarily under various brand names. The company was incorporated in 1950 and is headquartered in Mumbai, India.

Apie Signalai gyvai

Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.

Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.